A comparative evaluation of quality of life and life satisfaction in patients with psoriatic and rheumatoid arthritis (scientific article published on 19 April 2006)

Quality of life and prevalence of arthritis reported by 5,795 members of the Nordic Psoriasis Associations. Data from the Nordic Quality of Life Study

Q30705066

A comparative review of generic quality-of-life instruments

Q33881659

Severe Psoriasis – Oral Therapy with a New Retinoid

Q34690752

The suitability of quality-of-life questionnaires for psoriasis research: a systematic literature review

Q34841638

Psoriatic arthritis: epidemiology, clinical features, course, and outcome

Q35579437

Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films

Q41513883

Efficacy and safety of leflunomide in the treatment of psoriatic arthritis and psoriasis: a multinational, double-blind, randomized, placebo-controlled clinical trial

Q44930031

Functional disability and quality of life in patients with ankylosing spondylitis

Q47923896

The development and psychometric assessment of the Turkish version of the Nottingham Health Profile

Q48721441

Determinants of quality of life in a psoriasis population in northern Sweden.

Q53350155

Health-related quality of life in patients with psoriasis and atopic dermatitis measured with SF-36, DLQI and a subjective measure of disease activity

Q73598011

Health-related quality of life of patients with psoriatic arthritis: a comparison with patients with rheumatoid arthritis

Q73810982

The Nottingham Health Profile in rheumatoid arthritis: correlation with other health status measurements and clinical variables

Q73866871

Comparison of disability and quality of life in rheumatoid and psoriatic arthritis

Q74385099

The responsiveness of generic quality of life instruments in rheumatic diseases. A systematic review of randomized controlled trials

Q77904335

Sensitivity to change of generic quality of life instruments in patients with rheumatoid arthritis: preliminary findings in the generic health OMERACT study. OMERACT/ILAR Task Force on Generic Quality of Life. Life Outcome Measures in Rheumatology.

Q77904340

The measurement of life satisfaction

Q78944361

Etanercept treatment of psoriatic arthritis: safety, efficacy, and effect on disease progression

Q80330608

P433

issue

P921

main subject

rheumatoid arthritis

Q187255

life satisfaction

Q1117179

P304

page(s)

330-334

P577

publication date

2006-04-19

P1433

published in

Clinical Rheumatology

Q15754927

P1476

title

A comparative evaluation of quality of life and life satisfaction in patients with psoriatic and rheumatoid arthritis

P478

volume

Reverse relations

cites work (P2860)

Q48441269	A comparative evaluation of health related quality of life and depression in patients with fibromyalgia syndrome and rheumatoid arthritis
Q34229494	Adherence and resource use among patients treated with biologic drugs: findings from BEETLE study
Q39837952	Combination of skin, joint and quality of life outcomes with etanercept in psoriasis and psoriatic arthritis in the PRESTA trial
Q36033361	Comparison of health-related quality of life in rheumatoid arthritis, psoriatic arthritis and psoriasis and effects of etanercept treatment
Q88990740	Disease activity and biologic use in patients with psoriatic arthritis or rheumatoid arthritis
Q91967435	Disease features associated with a low disease impact in patients with psoriatic arthritis: results of a cross-sectional multicenter study
Q36310500	Foot problems in a group of patients with rheumatoid arthritis: an unmet need for foot care
Q48842622	Health-related quality of life and disability in patients with rheumatoid, early rheumatoid and early psoriatic arthritis treated with etanercept
Q47552588	Health-related quality of life of rheumatic disease patients treated in a specialized IPS in Medellin, Colombia
Q38010646	Impact of psoriatic arthritis on the patient: through the lens of the WHO International Classification of Functioning, Health, and Disability
Q35819025	Infliximab plus methotrexate is superior to methotrexate alone in the treatment of psoriatic arthritis in methotrexate-naive patients: the RESPOND study.
Q88687872	Long-term etanercept retention patterns and factors associated with treatment discontinuation: a retrospective cohort study using Canadian claims-level data
Q42293363	Minimal disease activity and impact of disease in psoriatic arthritis: a Spanish cross-sectional multicenter study
Q48099066	Psoriatic Arthritis Quality of Life questionnaire: translation, cultural adaptation and validation into Portuguese language.
Q37051504	Psoriatic arthritis epidemiology
Q51833799	Quality of life and life satisfaction in patients with Behçet's disease: relationship with disease activity.
Q91918289	Real world, big data cost of pharmaceutical treatment for rheumatoid arthritis in Greece
Q36718318	Self Management Behaviors in Rheumatoid Arthritis Patients and Associated Factors in Tehran 2013.
Q37208475	The Burden of Rheumatic Diseases: An Analysis of an Italian Administrative Database
Q34432846	The burden of psoriatic arthritis: a literature review from a global health systems perspective.
Q37172521	The health-related quality of life in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: a comparison with a selected sample of healthy people
Q48552102	Which clinical variables have the most significant correlation with quality of life evaluated by SF-36 survey in Croatian cohort of patient with ankylosing spondylitis and psoriatic arthritis?

P356	DOI	10.1007/S10067-006-0298-Y
P698	PubMed publication ID	16622591